Paper published in a journal (Scientific congresses and symposiums)
Ten years of Denosumab (DMAB) treatment in postmenopausal women with osteoporosis. Results from the FREEDOM Extension trial.
Bone, H.G.; Brandi, M.L.; Brown, J.P. et al.
2016In Osteoporosis International, 27 (Supplement 1), p. 135-136
Peer Reviewed verified by ORBi
 

Files


Full Text
Ten years of Denosumab (DMAB) treatment in postmenopausal women with osteoporosis. Results from the FREEDOM Extension trial.pdf
Publisher postprint (1.95 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Bone, H.G.
Brandi, M.L.
Brown, J.P.
Chapurlat, R.
Cummings, S.R.
Czerwinski, E.
Fahrleitner-Pammer, A.
Kendler, D.L.
Lippuner, K.
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Wittinghoff, E.
Daizadeh, S.
Wang, A.
Dakin, P.
Wagman, R.B.
Papapoulos, S.E.
More authors (6 more) Less
Language :
English
Title :
Ten years of Denosumab (DMAB) treatment in postmenopausal women with osteoporosis. Results from the FREEDOM Extension trial.
Publication date :
April 2016
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
Malaga, Spain
Event date :
du 14 au 17 avril 2016
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
27
Issue :
Supplement 1
Pages :
135-136
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 April 2016

Statistics


Number of views
250 (3 by ULiège)
Number of downloads
9 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi